• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

173865-33-3 (CDD3505)

1

Identification

CDD3505 CDD3505
Name CDD3505
Formula C22H17N3O2
MW 0.0
CAS No. 173865-33-3
EINECS
Smiles O=[N+]([O-])C1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1
Synonyms CDD-3505;CDD 3505; 4-nitro-1-trityl-1H-imidazole
InChI InChI=1S/C22H17N3O2/c26-25(27)21-16-24(17-23-21)22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-17H
2

Introduction

CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity. IC50: In Vitro: CDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol[1]. In Vivo:

Background Information

CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic <b>cytochrome P450IIIA (CYP3A)</b> activity. IC50: In Vitro: CDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol<sup>[1]</sup>. In Vivo: ......by MedChemexpress Co., Ltd.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000124468

Storage condition

Solubility

DMSO by CHEMSCENE, LLC
DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways Metabolic Enzyme/Protease
Target Cytochrome P450
Research Area Metabolic Disease
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
CDD3505 - No Development Reported
7

Safety Data of CDD3505

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
CHEMSCENE, LLC USA
MedChemexpress Co., Ltd. 5mg/USD150(In stock);10mg/USD240(In stock);50mg/USD850(In stock);100mg/USD1300(In stock) USA
Shanghai Haoyuan Chemexpress Co., Ltd. China
10

Related Products

Other Forms of 173865-33-3

Name CAS No Formula MW

Recommended Compounds in Cytochrome P450

Name CAS No Formula MW
Dafadine-A 1065506-69-5 C23H25N3O3 391.46
VT-464 (racemate) 1375603-36-3 C18H17F4N3O3 399.34
VT-464 1610537-15-9 C18H17F4N3O3 399.34
Isosilybin 72581-71-6 C25H22O10 482.44
Memantine (hydrochloride) 41100-52-1 C12H22ClN 215.76
Clarithromycin 81103-11-9 C38H69NO13 747.95
(+)-Ketoconazole 142128-59-4 C26H28Cl2N4O4 531.43
Ketoconazole 65277-42-1 C26H28Cl2N4O4 531.43
Galangin 548-83-4
Bergapten 484-20-8 C12H8O4 216.19
Naringin 10236-47-2 C27H32O14 580.53
Diosmetin 520-34-3 C16H12O6 300.26
Fenofibrate 49562-28-9 C20H21ClO4 360.83
4-hydroxy-7H-furo[3,2-g]chromen-7-one 486-60-2 C11H6O4 202.16
(R)-Talarozole 870093-23-5 C21H23N5S 377.51
Choline Fenofibrate 856676-23-8 C22H28ClNO5 421.91
Talarozole 201410-53-9 C21H23N5S 377.51
BAL 4815 241479-67-4 C22H17F2N5OS 437.47
Cobicistat 1004316-88-4 C40H53N7O5S2 776.02
Methoxsalen 298-81-7 C12H8O4 216.19

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

CDD3505

Tags: buy 173865-33-3 IC50 | 173865-33-3 price | 173865-33-3 cost | 173865-33-3 solubility | 173865-33-3 purchase | 173865-33-3 manufacturer | 173865-33-3 research buy | 173865-33-3 order | 173865-33-3 MSDS | 173865-33-3 chemical structure | 173865-33-3 Storage condition | 173865-33-3 molecular weight | 173865-33-3 mw | 173865-33-3 datasheet | 173865-33-3 supplier | 173865-33-3 cell line | 173865-33-3 NMR | 173865-33-3 MS | 173865-33-3 IR | 173865-33-3 solubility | 173865-33-3 Safe information | 173865-33-3 Qc and Spectral Information | 173865-33-3 Clinical Information | 173865-33-3 Clinical Trial | 173865-33-3 Route of Synthesis | 173865-33-3 storage condition | 173865-33-3 diseases and conditions | 173865-33-3 flash point | 173865-33-3 boiling point | 173865-33-3 melting point | 173865-33-3 storage condition | 173865-33-3 brand